A model that combines a host biomarker with a generative artificial intelligence (AI) analysis of electronic medical records ...

Skinobs’ founder and CEO Anne Charpentier examines how biomarker-based diagnostics are reshaping dermocosmetics and ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

Decode Age secures ₹14.48 crore in Pre Series A funding to advance ageing biology and microbiome research for healthy ...

Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of Oncology (VHIO), which forms part of the Vall d'Hebron Campus, underscore the ...

A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer’s disease. Researchers discovered that LPCs—compounds that transport a variety of healthy ...

First Study to Use a pTau217 Blood Test to Detect Alzheimer's Disease Early and at ScaleCARLSBAD, Calif., /PRNewswire/ -- ALZpath, Inc., a ...

Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs. 14.48 crore in its Pre Series A funding round led by Dr Krishna ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...